As demand for effective diabetes and weight-management treatments continues to grow, this innovation could help improve treatment adherence, expand patient access, and strengthen Indias fight against chronic metabolic diseases.
Semaglutide: Semaglutide mimics the action of the GLP-1 hormone, which regulates appetite and food intake
Although it may seem like just milk, raw milk is more than a trend, its a major health risk
Individuals who may warrant closer monitoring include: Those with a personal or family history of depression , anxiety, or other mood disorders People who have previously experienced mood changes on other weight-loss medications or GLP-1-based therapies Individuals with eating disorders or a complex relationship with food , for whom appetite suppression may have psychological implications (see NICE guideline NG69: Eating disorders: recognition and treatment) [10] Those experiencing significant life stressors alongside starting a new treatment People with poorly controlled type 2 diabetes , where fluctuating blood glucose levels both hypoglycaemia and hyperglycaemia can independently affect mood, concentration, and emotional wellbeing It is also worth acknowledging that obesity itself is associated with higher rates of depression and anxiety, and that the psychological experience of rapid body weight change whether positive or negative can be emotionally complex
